 
|
 Biopharmaceuticals
 Clinical stage biotech company pursuing transformative
approach to treating chronic pain and related conditions. Spin out of assets
from Roche.
Boston, MA  Biotech product platform company focused on discovery and
development of novel targets in infectious diease.
New Haven, CT  Developer of new antiviral medicines for the treatment of life-threatening diseases.
Durham, NC  Novel product platform focused on generating new NCEs
through the use of deuterium based chemistry on the known molecular
structures of approved pharmaceutical products.
Lexington, MA  Biopharmaceutical company focused on the development of
novel analgesics with the potential for commercially attractive efficacy,
responder-rate and tolerability profiles.
Cambridge, UK  Clinical stage biopharma company focused on completing phase
3 clinical development and registration of dalbavancin, a late stage
lipoglycopeptide antibiotic. Spin out of Vicuron division of Pfizer.
North Morristown, NJ  Product platform company with a novel, implantable osmotic
pump. Lead program is exenatide, for the treatment of type 2 diabetes.
Emeryville, CA  Ophthalmologic focused specialty pharmaceutical company.with
commercial and clnical stage products.
Ticker: ISTA Irvine, CA  A start-up company focused on novel broad spectrum antibiotic drug development targeting highly resistant organisms.
Menlo Park, CA  Product platform biopharmaceutical company pursuing an
industrial approach to pathway-based drug discovery.
San Diego, CA  A pharmaceutical company focused on bone related diseases.
New Haven, CT  Global specialty pharmaceutical company that sources,
develops, manufactures, and markets specialist and prescription
pharmaceutical and health care products including branded, generic, and OTC
medications.
Zurich, Switzerland  Early clinical stage biotech company focused on novel
treatments for Hepatitis- C and HIV.
San Francisco, CA  Clinical stage product platform company focused on
development of novel products for the treatment and prevention of
inflammatory, obstructive and allergic conditions in respiratory diseases.
Spin out of technology from Nektar.
Redwood City, CA  Clinical stage product platform company targeting discovery
and development of non-absorbed polymeric drugs in cardiovascular and renal
diseases. Spinout of technology from Amgen/Ilypsa.
Santa Clara, CA  Clinical stage oncology company with lead program in phase 3
in first-line metastatic breast cancer.
New Haven, CT  Clinical stage biopharmaceutical company targeting novel
treatments for fibrosis. Spin out of assets from Biogen-Idec.
Cambridge, MA  Clinical stage biopharmaceutical company dedicated to discovering,
developing and delivering therapies for patients with rare conditions and unmet medical need.
Ticker: GEVA Lexington, MA  Clinical stage biopharmaceutical company with a phase 3
program in irritable bowel syndrome. Spin out of asset from Merck KgA.
San Diego, CA  NDA stage specialty pharmaceutical company developing
products that utilize a buccal delivery technology. Lead program in
insomnia.
Ticker: TSPT Pt. Richmond, CA  Clinical stage product platform company developing vaccines
for both pandemic and seasonal influenza.
Cranbury, NJ  Clinical stage biotech company pursuing a monthly hGH using Amunix’s XTEN technology.
Mountain View, CA |